Get emailed when LENZ changes direction
Factor Model (net -1.3)
Factor Model
net -1.3
Est. Revisions
-0.6
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
+0.0
Narrative Gap
+0.0
Analysis pending — waiting for first signal cycle.
Evidence
15h ago
HC Wainwright & Co. main LENZ: Buy → Buy
8d ago
Insider buy by MCCOLLUM JAMES W (LENZ): $501,093
8d ago
Insider buy by CHEVALLARD DANIEL R (LENZ): $49,988
8d ago
Insider sell by VERSANT VENTURE CAPITAL VI, L.P. (LENZ): $10,150,000
8d ago
Insider sell by VERSANT VENTURE CAPITAL VI, L.P. (LENZ): $10,107,818
8d ago
Insider sell by VERSANT VENTURE CAPITAL VI, L.P. (LENZ): $10,255,244
8d ago
Insider sell by VERSANT VENTURE CAPITAL VI, L.P. (LENZ): $10,352,017
8d ago
Insider buy by MCCOLLUM JAMES W (LENZ): $239,278
5 older signals
8d ago
Insider buy by CHEVALLARD DANIEL R (LENZ): $50,017
8d ago
Insider buy by GEORGE JEFFREY P. (LENZ): $49,890
8d ago
Insider buy by SCHIMMELPENNINK EVERT B. (LENZ): $251,411
8d ago
Insider buy by CHEVALLARD DANIEL R (LENZ): $64,275
Fundamentals & Data ▾
LENZ Therapeutics, Inc.
Healthcare · Biotechnology
Mkt Cap
$318M
Beta
2.29
52w Range
$8.25 - $50.40
Short Interest
9.0M 49.54%
Days to Cover
7.8 +2%
Technicals
downtrend
from 52w Hi
-0.5%
1w return
+5.2%
Insiders
selling
7B / 8S
Analysts
mixed
EPS Estimate
$-1.03
-11.3% 30d
2up / 2dn
Est. Dispersion
68%
7 analysts
Analyst Target
$41
$20 - $60
Options P/C
2.00
Insider Cluster
strong buy
4B / 2S (officer)
Fund Convergence
strong
Citadel, Two Sigma, D.E. Shaw
Financials
Revenue
$2M
FCF
$-33M
Op Margin
-2422%
Momentum:
decelerating
Top Holders
Citadel
$3M
Two Sigma
$1M
D.E. Shaw
Recent Filings & Data
insider trade
21
net selling
· $66,864,161 sold
· $1,205,952 bought
6 insiders · 21 transactions (30d)
Recent transactions
CHEVALLARD DANIEL R · buy · $64,275
SCHIMMELPENNINK EVERT B. · buy · $251,411
GEORGE JEFFREY P. · buy · $49,890
OLSSON SHAWN · sell · $261,022
OLSSON SHAWN · exercise · $20,800
CHEVALLARD DANIEL R · buy · $50,017
MCCOLLUM JAMES W · buy · $239,278
VERSANT VENTURE CAPITAL VI, L.P. · sell · $10,352,017
VERSANT VENTURE CAPITAL VI, L.P. · sell · $5,714,356
VERSANT VENTURE CAPITAL VI, L.P. · sell · $7,423,920
VERSANT VENTURE CAPITAL VI, L.P. · sell · $10,255,244
VERSANT VENTURE CAPITAL VI, L.P. · sell · $6,506,784
VERSANT VENTURE CAPITAL VI, L.P. · sell · $6,093,000
VERSANT VENTURE CAPITAL VI, L.P. · sell · $10,107,818
VERSANT VENTURE CAPITAL VI, L.P. · sell · $10,150,000
OLSSON SHAWN · exercise · $2,912
SCHIMMELPENNINK EVERT B. · exercise · $4,368
OLSSON SHAWN · exercise · $6,933
SCHIMMELPENNINK EVERT B. · exercise · $46,800
CHEVALLARD DANIEL R · buy · $49,988
MCCOLLUM JAMES W · buy · $501,093
13 signals · latest 15h ago
Get alerted when LENZ changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.